Search
Syndax Pharmaceuticals Inc
SNDXAdd to Watchlist
20.810USD
-0.400-1.89%
Close 07-24 16:00（ET）Quotes delayed by 15 min
1.82BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-24The current earnings forecast score of Syndax Pharmaceuticals Inc is 8.86, ranking 44 out of 386 in the Biotechnology & Medical Research industry. The average price target is 38.00, with a high of 56.00 and a low of 27.00.
Analyst Rating
Based on
13
analysts
Buy
Current Rating
40.545
Target Price
+91.16%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Syndax Pharmaceuticals Inc
SNDX
13
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Syndax Pharmaceuticals Inc's expected revenue for the next quarter?
Syndax Pharmaceuticals Inc's expected revenue is 79.32M.
What is Syndax Pharmaceuticals Inc's price target?
Analysts forecast that Syndax Pharmaceuticals Inc's price target is USD 38.00, with the highest forecast at USD 56.00 and the lowest forecast at USD 27.00.
How have Syndax Pharmaceuticals IncSNDX's recent earnings per share performed?
The market expectation was USD -0.48, while Syndax Pharmaceuticals IncSNDX's earnings per share (EPS) for the previous quarter was USD -0.78. EPS for the next quarter is expected at USD -0.44.
What is the analyst rating for Syndax Pharmaceuticals Inc?
Based on the ratings of Syndax Pharmaceuticals Inc's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.